S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
3 Value Stocks Too Small For Buffett’s Portfolio
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Foot Locker Builds Up Another Head of Steam; Gains Imminent
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
3 Value Stocks Too Small For Buffett’s Portfolio
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Foot Locker Builds Up Another Head of Steam; Gains Imminent
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
3 Value Stocks Too Small For Buffett’s Portfolio
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Foot Locker Builds Up Another Head of Steam; Gains Imminent
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
3 Value Stocks Too Small For Buffett’s Portfolio
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Foot Locker Builds Up Another Head of Steam; Gains Imminent
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
NASDAQ:PKBO

Peak Bio (PKBO) Stock Price, News & Analysis

$0.0051
0.00 (0.00%)
(As of 03/28/2024 ET)
Today's Range
$0.0051
$0.0051
50-Day Range
$0.00
$0.05
52-Week Range
$0.00
$1.00
Volume
N/A
Average Volume
1,011 shs
Market Capitalization
$115,413.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
PKBO stock logo

About Peak Bio Stock (NASDAQ:PKBO)

Peak Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of patients with inflammatory, cancer, and rare and specialty diseases. The company's lead product candidate is PHP-303, which is in phase 2 clinical study for the treatment of alpha-1 antitrypsin deficiency and acute respiratory distress syndrome. It also develops Trop2 PH1, an antibody-drug-conjugate for solid tumors. The company was founded in 2020 and is based in Pleasanton, California.

PKBO Stock Price History

PKBO Stock News Headlines

“The Stock Market’s Bull Run is Far from Over” -Barrons
Barron's reports that the "stock market's bull run is FAR from over…" And recent economic growth will fuel the price of select stocks in the coming months!
Pyramid Peak Foundation's Net Worth
Peak Bio Raises Capital via Convertible Promissory Notes
“The Stock Market’s Bull Run is Far from Over” -Barrons
Barron's reports that the "stock market's bull run is FAR from over…" And recent economic growth will fuel the price of select stocks in the coming months!
BioPharma Uplists to OTCQB
Peak Bio, Inc. Announces Up-listing to OTCQB Market
Finding peak travel outfits with Alan Cumming
What Is Going on With Peak Bio (PKBO) Stock Today?
See More Headlines
Receive PKBO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Peak Bio and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
3/29/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:PKBO
Fax
N/A
Employees
21
Year Founded
N/A

Profitability

Net Income
$-13,090,000.00
Pretax Margin
-4,537.38%

Debt

Sales & Book Value

Annual Sales
$610,000.00
Book Value
($0.40) per share

Miscellaneous

Free Float
18,129,000
Market Cap
$115,413.00
Optionable
Not Optionable
Beta
0.12
(Almost) Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Key Executives

  • Dr. Hoyoung Huh M.D. (Age 55)
    Ph.D., Executive Chairman (Leave of Absence)
    Comp: $1.67M
  • Dr. Stephen LaMond M.B.A. (Age 62)
    Pharm.D., PharmD MBA, Interim CEO, COO, Secretary & Director
    Comp: $499.17k
  • Dr. Satyajit Mitra Ph.D. (Age 50)
    Head of Oncology & Executive Director
    Comp: $317.22k
  • Mr. Timothy M. Cunningham CPA (Age 61)
    M.B.A., Acting Chief Financial Officer
  • Ms. Moddy Wong
    Director of Human Resources
  • Ms. Divya Patel
    Controller & Treasurer

PKBO Stock Analysis - Frequently Asked Questions

How have PKBO shares performed in 2024?

Peak Bio's stock was trading at $0.1875 at the beginning of the year. Since then, PKBO shares have decreased by 97.3% and is now trading at $0.0051.
View the best growth stocks for 2024 here
.

How do I buy shares of Peak Bio?

Shares of PKBO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:PKBO) was last updated on 3/29/2024 by MarketBeat.com Staff

From Our Partners